Premium
Annexon Inc (ANNX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Dr. William H. CarsonIndependent Director | 8,00k | 46,24k | Automatic Acquisition | 5,78 | 78,41k | 11,36% |
| 2026-04-10 | Dr. William H. CarsonIndependent Director | 8,00k | 49,60k | Automatic Acquisition | 6,20 | 70,41k | 12,82% |
| 2026-03-10 | Dr. William H. CarsonIndependent Director | 8,00k | 45,36k | Automatic Acquisition | 5,67 | 62,41k | 14,70% |
| 2026-03-02 | Dr. Ted YednockExec. VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board | -5,57k | 30,17k | Vente | 5,42 | 154,16k | -3,48% |
| 2026-03-02 | Dr. Dean R. ArtisChief Scientific Officer & Exec. VP | -5,89k | 32,00k | Vente | 5,43 | 74,62k | -7,32% |
| 2026-03-02 | Dr. Jamie DananbergExec. VP & Chief Medical Officer | -5,82k | 31,60k | Vente | 5,43 | 24,36k | -19,29% |
| 2026-03-02 | Mr. Michael OverdorfExec. VP & Chief Business Officer | -4,34k | 23,52k | Vente | 5,42 | 77,15k | -5,32% |
| 2026-03-02 | Ms. Jennifer LewExec. VP, CFO & Corporate Secretary | -5,57k | 30,16k | Vente | 5,42 | 65,23k | -7,86% |
| 2026-02-18 | Dr. Ted YednockExec. VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board | -7,86k | 40,15k | Vente | 5,11 | 97,23k | -7,48% |
| 2026-02-18 | Mr. Michael OverdorfExec. VP & Chief Business Officer | -6,23k | 31,75k | Vente | 5,10 | 66,50k | -8,56% |
| 2026-02-18 | Dr. Dean R. ArtisChief Scientific Officer & Exec. VP | -5,29k | 26,98k | Vente | 5,10 | 65,52k | -7,47% |
| 2026-02-18 | Dr. Jamie DananbergExec. VP & Chief Medical Officer | -5,29k | 26,98k | Vente | 5,10 | 15,19k | -25,83% |
| 2026-02-18 | Ms. Jennifer LewExec. VP, CFO & Corporate Secretary | -7,85k | 40,12k | Vente | 5,11 | 55,80k | -12,33% |
| 2025-12-30 | Dr. William H. CarsonIndependent Director | 4,12k | 20,66k | Automatic Acquisition | 5,02 | 54,41k | 8,18% |
| 2025-12-01 | Ms. Jung E. ChoiIndependent Director | 33,00k | 138,27k | Achat | 4,19 | 33,00k | - |
| 2025-12-01 | Dr. William H. CarsonIndependent Director | 4,12k | 18,39k | Automatic Acquisition | 4,47 | 50,29k | 8,91% |
| 2025-11-20 | Alerce Investment Management L.P.Société | 822,61k | 3,60M | Achat | 4,28 - 4,48 | 8,92M | 10,16% |
| 2025-11-17 | Alerce Investment Management L.P.Société | 1,50M | 5,06M | Achat | 2,99 - 3,94 | 8,10M | 22,73% |
| 2025-10-30 | Dr. William H. CarsonIndependent Director | 4,12k | 13,04k | Automatic Acquisition | 3,17 | 46,18k | 9,78% |
| 2025-09-30 | Dr. William H. CarsonIndependent Director | 4,12k | 12,55k | Automatic Acquisition | 3,05 | 42,06k | 10,84% |
| 2025-09-02 | Dr. William H. CarsonIndependent Director | 4,12k | 8,60k | Automatic Acquisition | 2,09 | 37,95k | 12,16% |
| 2025-07-30 | Dr. William H. CarsonIndependent Director | 4,12k | 10,00k | Automatic Acquisition | 2,43 | 33,83k | 13,85% |
| 2025-07-14 | Ms. Jennifer LewExec. VP, CFO & Corporate Secretary | -1,12k | 2,88k | Vente | 2,58 | 44,33k | -2,46% |
| 2025-07-14 | Mr. Michael OverdorfExec. VP & Chief Business Officer | -853,00 | 2,23k | Vente | 2,61 | 53,40k | -1,57% |
| 2025-07-14 | Dr. Ted YednockExec. VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board | -1,12k | 2,88k | Vente | 2,58 | 105,08k | -1,05% |
| 2025-06-30 | Dr. William H. CarsonIndependent Director | 4,12k | 10,12k | Automatic Acquisition | 2,46 | 29,72k | 16,07% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
